These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17893290)

  • 1. Lost in translation: again, another failed neuroprotection trial.
    Brew BJ
    Neurology; 2007 Sep; 69(13):1308-9. PubMed ID: 17893290
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
    Schifitto G; Zhang J; Evans SR; Sacktor N; Simpson D; Millar LL; Hung VL; Miller EN; Smith E; Ellis RJ; Valcour V; Singer E; Marra CM; Kolson D; Weihe J; Remmel R; Katzenstein D; Clifford DB;
    Neurology; 2007 Sep; 69(13):1314-21. PubMed ID: 17652642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editor review of "Erythropoietin as a neuroprotective agent in traumatic brain injury" by Mammis et al.
    Ausman JI
    Surg Neurol; 2009 May; 71(5):525. PubMed ID: 19386291
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
    Hajieva P; Mocko JB; Moosmann B; Behl C
    J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection in spinal cord injury.
    Wyndaele JJ
    Spinal Cord; 2009 Oct; 47(10):715. PubMed ID: 19794416
    [No Abstract]   [Full Text] [Related]  

  • 6. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
    Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mitochondrial ATP-sensitive potassium channels--a novel approach to neuroprotection.
    Busija DW; Lacza Z; Rajapakse N; Shimizu K; Kis B; Bari F; Domoki F; Horiguchi T
    Brain Res Brain Res Rev; 2004 Nov; 46(3):282-94. PubMed ID: 15571770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations.
    Pocernich CB; Sultana R; Mohmmad-Abdul H; Nath A; Butterfield DA
    Brain Res Brain Res Rev; 2005 Dec; 50(1):14-26. PubMed ID: 15890409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of published reports on neuroprotection in spinal cord injury.
    Onose G; Anghelescu A; Muresanu DF; Padure L; Haras MA; Chendreanu CO; Onose LV; Mirea A; Ciurea AV; El Masri WS; von Wild KR
    Spinal Cord; 2009 Oct; 47(10):716-26. PubMed ID: 19597522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
    Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
    J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo neuroprotection by a creatine-derived compound: phosphocreatine-Mg-complex acetate.
    Perasso L; Adriano E; Ruggeri P; Burov SV; Gandolfo C; Balestrino M
    Brain Res; 2009 Aug; 1285():158-63. PubMed ID: 19523930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glatiramer acetate positively influences spinal motoneuron survival and synaptic plasticity after ventral root avulsion.
    Scorisa JM; Zanon RG; Freria CM; de Oliveira AL
    Neurosci Lett; 2009 Feb; 451(1):34-9. PubMed ID: 19103252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I can't get no satisfaction: still no neuroprotection for Parkinson disease.
    Ahlskog JE
    Neurology; 2007 Oct; 69(15):1476-7. PubMed ID: 17923609
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
    Takada-Takatori Y; Kume T; Ohgi Y; Izumi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
    J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
    Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
    Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection and neuroplasticity - a holistic approach and future perspectives.
    Muresanu DF
    J Neurol Sci; 2007 Jun; 257(1-2):38-43. PubMed ID: 17331543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis and neuroprotective therapy trial in chronic degenerative diseases. Status of antioxidants].
    Gerlach M; Riederer P
    Med Klin (Munich); 1996 Mar; 91(3):163-70. PubMed ID: 8628203
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroprotective therapy for HIV dementia.
    Turchan J; Sacktor N; Wojna V; Conant K; Nath A
    Curr HIV Res; 2003 Oct; 1(4):373-83. PubMed ID: 15049424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors.
    Arien-Zakay H; Lecht S; Bercu MM; Tabakman R; Kohen R; Galski H; Nagler A; Lazarovici P
    Exp Neurol; 2009 Mar; 216(1):83-94. PubMed ID: 19070617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus.
    Hwang IK; Yoo KY; Li H; Park OK; Lee CH; Choi JH; Jeong YG; Lee YL; Kim YM; Kwon YG; Won MH
    J Neurosci Res; 2009 Jul; 87(9):2126-37. PubMed ID: 19235887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.